WAVE Life Sciences Ltd (WVE.OQ)
16 Jul 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|58||2012||Independent Chairman of the Board|
|43||2013||President, Chief Executive Officer, Director|
|47||2016||Chief Financial Officer|
|39||2017||Senior Vice President, Corporate Development & Portfolio Management|
|56||2014||Senior Vice President, Head of Drug Discovery|
- BRIEF-Wave Life Sciences Reports Qtrly Loss Per Share $1.26
- BRIEF-Wave Life Sciences And Deep Genomics Form Collaboration To Discover Therapies For Genetic Neuromuscular Disorders
- BRIEF-Wave Life Ended 2017 With $142.5 Mln In Cash, Equivalents
- BRIEF-Wave Life Sciences And Takeda Form Strategic Collaboration To Advance Therapies For Central Nervous System Disorders